Read More Pharma Industry News EC grants approval for GSK’s Omjjara for treatment of myelofibrosis patients with anaemia In a landmark decision, the European Commission has approved GSK plc’s Omjjara (momelotinib), introducing a revolutionary treatment for… byPallavi MadhirajuFebruary 5, 2024